Items where Author is "Angelis, Aris"

Article

Angelis, Aris ORCID: 0000-0002-0261-4634, Aggarwal, Ajay, Miners, Alec, Cairns, John and Briggs, Andrew (2023) The Innovative Medicines Fund: a universal model for faster and fairer access to new promising medicines or a Trojan horse for low-value creep? Journal of the Royal Society of Medicine, 116 (10). 324 - 330. ISSN 0141-0768

Angelis, Aris ORCID: 0000-0002-0261-4634, Harker, Martin, Cairns, John, Seo, Mikyung Kelly, Legood, Rosa, Miners, Alec, Wiseman, Virginia, Chalkidou, Kalipso, Grieve, Richard and Briggs, Andrew (2023) The evolving nature of Health Technology Assessment: a critical appraisal of NICE’s new methods manual. Value in Health, 26 (10). 1503 - 1509. ISSN 1098-3015

Angelis, Aris ORCID: 0000-0002-0261-4634, Montibeller, Gilberto Neto and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2023) A structured methodology for essential medicines lists and health emergency stockpiles: experience with the Emergency Medicines Buffer Stock in the United Kingdom. Social Science and Medicine, 337. ISSN 0277-9536

Angelis, Aris ORCID: 0000-0002-0261-4634, Polyakov, Roman, Wouters, Olivier J. ORCID: 0000-0002-2514-476X, Torreele, Els and McKee, Martin (2023) High drug prices are not justified by industry’s spending on research and development. BMJ, 380 (8371). ISSN 1756-1833

Angelis, Aris ORCID: 0000-0002-0261-4634, Suarez Alonso, Carlos, Kyriopoulos, Ilias ORCID: 0000-0002-3932-8228 and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2022) Funding sources of therapeutic and vaccine clinical trials for COVID-19 vs non-COVID-19 indications, 2020-2021. JAMA network open, 5 (8). ISSN 2574-3805

Angelis, Aris ORCID: 0000-0002-0261-4634 and Phillips, Lawrence D. (2021) Advancing structured decision-making in drug regulation at the FDA and EMA. British Journal of Clinical Pharmacology, 87 (2). 395 - 405. ISSN 0306-5251

Angelis, Aris ORCID: 0000-0002-0261-4634, Baltussen, Rob and Tervonen, Tommi (2021) The need for novel approaches in assessing the value of COVID-19 vaccines. American Journal of Public Health, 111 (2). 205 - 208. ISSN 0090-0036

Angelis, Aris ORCID: 0000-0002-0261-4634, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Hackshaw, Allan (2020) Recalibrating health technology assessment methods for cell and gene therapies. PharmacoEconomics, 38 (12). pp. 1297-1308. ISSN 1170-7690

Angelis, Aris ORCID: 0000-0002-0261-4634, Thursz, Mark, Ratziu, Vlad, O'Brien, Alistair, Serfaty, Lawrence, Canbay, Ali, Schiefke, Ingolf, Bana e Costa, João C., Lecomte, Pascal and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2020) Early health technology assessment during nonalcoholic steatohepatitis drug development: a two-round, cross-country, multicriteria decision analysis. Medical Decision Making, 40 (6). 830 - 845. ISSN 0272-989X

Angelis, Aris ORCID: 0000-0002-0261-4634, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Phillips, Lawrence D. (2020) ICER value framework 2020 update: recommendations on the aggregation of benefits and contextual considerations. Value in Health, 23 (8). 1040 - 1048. ISSN 1098-3015

Angelis, Aris ORCID: 0000-0002-0261-4634, Linch, Mark, Montibeller, Gilberto, Molina Lopez, Maria Teresa, Zawada, Anna, Orzel, Kinga, Arickx, Francis, Espin, Jaime and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2020) Multiple criteria decision analysis for HTA across four EU member states: piloting the Advance Value Framework. Social Science & Medicine, 246. ISSN 0277-9536

Tervonen, Tommi, Angelis, Aris ORCID: 0000-0002-0261-4634, Hockley, Kimberley, Pignatti, Francesco and Phillips, Lawrence D. (2019) Quantifying preference in drug benefit-risk decisions. Clinical Pharmacology and Therapeutics, 106 (5). pp. 955-959. ISSN 0009-9236

Kanavos, Panos ORCID: 0000-0001-9518-3089, Angelis, Aris ORCID: 0000-0002-0261-4634 and Drummond, Michael (2019) An EU-wide approach to HTA: an irrelevant development or an opportunity not to be missed? European Journal of Health Economics, 20 (3). pp. 329-332. ISSN 1618-7598

Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2018) Comment on: “Does MCDA trump CEA?”. Applied Health Economics and Health Policy. ISSN 1175-5652

Angelis, Aris ORCID: 0000-0002-0261-4634 (2018) Evaluating the benefits of new drugs in health technology assessment using multiple criteria decision analysis: a case study on metastatic prostate cancer with the dental and pharmaceuticals benefits agency (TLV) in Sweden. Medical Decision Making: Policy and Practice, 3 (2). ISSN 2381-4683

Angelis, Aris ORCID: 0000-0002-0261-4634, Lange, Ansgar and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2018) Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries. European Journal of Health Economics, 19 (1). pp. 123-152. ISSN 1618-7598

Angelis, Aris ORCID: 0000-0002-0261-4634, Montibeller, Gilberto, Hochhauser, Daniel and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2017) Multiple criteria decision analysis in the context of health technology assessment: a simulation exercise on metastatic colorectal cancer with multiple stakeholders in the English setting. BMC Medical Informatics and Decision Making, 17 (149). ISSN 1472-6947

Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2017) Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: the Advance Value Framework. Social Science & Medicine, 188. pp. 137-156. ISSN 0277-9536

Jackson, Timothy L., Nicod, Elena, Angelis, Aris ORCID: 0000-0002-0261-4634, Grimaccia, Federico, Pringle, Edward and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2017) Pars plana vitrectomy for diabetic macular edema: a systematic review, meta-analysis, and synthesis of safety literature. Retina, 37 (5). pp. 886-895. ISSN 1539-2864

Angelis, Aris ORCID: 0000-0002-0261-4634, Tordrup, David and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2017) Is the funding of public national health systems sustainable over the long term? Evidence from eight OECD countries. Global Policy, 8 (S2). pp. 7-22. ISSN 1758-5880

Angelis, Aris ORCID: 0000-0002-0261-4634, Kanavos, Panos ORCID: 0000-0001-9518-3089 and Montibeller, Gilberto (2017) Resource allocation and priority setting in health care: a multi-criteria decision analysis problem of value? Global Policy, 8 (S2). pp. 76-83. ISSN 1758-5880

Nicod, Elena, Jackson, Timothy L., Grimaccia, Federico, Angelis, Aris ORCID: 0000-0002-0261-4634, Costen, Marc, Haynes, Richard, Hughes, Edward, Pringle, Edward, Zambarakji, Hadi and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2016) Direct cost of pars plana vitrectomy for the treatment of macular hole, epiretinal membrane and vitreomacular traction: a bottom-up approach. European Journal of Health Economics, 17 (8). pp. 991-999. ISSN 1618-7598

Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2016) Critique of the American Society of Clinical Oncology value assessment framework for cancer treatments: putting methodologic robustness first. Journal of Clinical Oncology, 34 (24). pp. 2935-2936. ISSN 0732-183X

Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2016) Value-based assessment of new medical technologies: towards a robust methodological framework for the application of multiple criteria decision analysis in the context of health technology assessment. PharmacoEconomics, 34 (5). pp. 435-446. ISSN 1170-7690

Angelis, Aris ORCID: 0000-0002-0261-4634, Tordrup, David and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2015) Socio-economic burden of rare diseases: a systematic review of cost of illness evidence. Health Policy, 119 (7). pp. 964-979. ISSN 0168-8510

Tervonen, Tommi, Naci, Huseyin ORCID: 0000-0002-7192-5751, van Valkenhoef, Gert, Ades, Anthony E., Angelis, Aris ORCID: 0000-0002-0261-4634, Hillege, Hans L. and Postmus, Douwe (2015) Applying multiple criteria decision analysis to comparative benefit-risk assessment: choosing among statins in primary prevention. Medical Decision Making, 35 (7). pp. 859-871. ISSN 0272-989X

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Angelis, Aris ORCID: 0000-0002-0261-4634 (2014) Acquiring pharmaceutical industry assets in the UK: 1 + 1 = 1? Pharmaceutical Medicine, online. ISSN 1178-2595

Tordrup, David, Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2013) Preferences on policy options for ensuring the financial sustainability of health care services in the future: results of a stakeholder survey. Applied Health Economics and Health Policy, 11 (6). pp. 639-652. ISSN 1175-5652

Jackson, Timothy L., Nicod, Elena, Angelis, Aris ORCID: 0000-0002-0261-4634, Grimaccia, Federico, Prevost, Andrew T., Simpson, Andrew R.H. and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2013) Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy. Retina, 33 (10). pp. 2012-2017. ISSN 0275-004X

Jackson, Timothy L., Nicod, Elena, Angelis, Aris ORCID: 0000-0002-0261-4634, Grimaccia, Federico, Prevost, Toby, Simpson, Andrew and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2013) Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. Retina, 33 (6). pp. 1099-1108. ISSN 1539-2864

Jackson, Timothy, Nicod, Elena, Simpson, Andrew, Angelis, Aris ORCID: 0000-0002-0261-4634, Grimaccia, Federico and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2013) Symptomatic vitreomacular adhesion. Retina, 33 (8). pp. 1503-1511. ISSN 1539-2864

Monograph

Kanavos, Panos ORCID: 0000-0001-9518-3089 and Angelis, Aris ORCID: 0000-0002-0261-4634 (2013) Multiple criteria decision analysis for valuebased assessment of new medical technologies:a conceptual framework. LSE Health working papers (33). LSE Health, London, UK.

Online resource

Angelis, Aris ORCID: 0000-0002-0261-4634 (2016) Why are the prices of new medicines so high and what can we do about it? (F8). European Health Forum Gastein (30 Sep 2016). Website.

Angelis, Aris ORCID: 0000-0002-0261-4634 and Kanavos, Panos ORCID: 0000-0001-9518-3089 (2015) Large scale mergers and acquisitions in the pharmaceutical industry: 1 + 1 = 1? Health and Social Care Blog (12 Nov 2015). Website.